Digital health briefing Trends & Statistics
Unapproved AI use in hospitals grows as doctors seek faster workflows
Clinicians and staff adopt “shadow AI” tools to move faster, exposing gaps in hospital AI strategy.
Weight loss drug market edges toward a more crowded Big Pharma field
Roche’s obesity drug results show up to 22.5% weight loss, hinting at future competition for Novo and Lilly.
Women’s telehealth Wisp expands national footprint and services with acquisition
Wisp acquires TBD Health to scale nationwide, adding clinics and diagnostics to meet rising demand for virtual care among women.
3 pharma headwinds that will likely lose force in 2026
Major regulatory upheaval affecting pharma’s core business is unlikely to materialize this year.
Baby boomers drive CTV’s lead in healthcare and pharma ad recall, per EMARKETER survey
51% US consumers now notice healthcare and pharma advertising on CTV, putting it ahead of search and social.
GLP-1 drugs expected to drive 2026 pharma sales
Lilly’s tirzepatide is projected to top 2026 sales as pills and uses beyond diabetes and weight loss expand demand.
Watchdog raises concerns over consumer use of health AI chatbots
Heavy consumer AI health use raises pressure on OpenAI and peers to tighten safeguards fast.
AI chatbots are becoming a go-to support tool for students, US schools say
Young people overwhelmingly confide in chatbots even as questions around safety and mental health risks mount.
Amazon adds AI health assistant to One Medical app
Amazon bets on AI health guidance paired with doctor access—something ChatGPT and Claude don’t offer.
Insurers face heat over rising costs as UnitedHealth pledges ACA rebates
UnitedHealth will issue ACA refunds, but the move mirrors industry pledges—headline-friendly and light on accountability.
Pharma prescription drug TV advertising spend reached nearly $6 billion in 2025
Prescription drug advertising approached $6 billion in 2025, led by weight loss, mental health, and cancer medications.
35% of patients would switch doctors over poor digital experiences
More than a third of patients will switch doctors who don’t modernize the experience.
Fresh data backs Tylenol safety as lawsuits, FDA warnings loom
Rigorous data gives acetaminophen brands footing to reassure pregnant consumers.
Ozempic campaign borrows Apple’s ad playbook, but with side effect disclosures
The riff on Apple’s Mac versus PC campaign lightens the pharma tone while also leaning more into disclosures.
Women’s healthcare opportunities extend far beyond gender-specific conditions
The biggest women’s health opportunity may actually be in common diseases that affect women differently and go ignored.
5 important healthcare and pharma developments from JPM 2026
AI’s growing clout in healthcare and pharma and candid confessions from drugmaker CEOs dominated the narrative at JPM 2026.
FDA moves to drop suicide risk warnings from GLP-1 weight loss drugs
The change could ease stigma and fuel uptake, especially as oral weight loss drugs hit the market.
GLP-1 compounder lawsuit spotlights rising telehealth exclusivity wars
Novo and Lilly prohibit telehealth partners from offering compounded GLP-1s, eroding compounders’ ability to distribute.
Trump proposes new healthcare plan with broad changes across the system
It targets pharma margins, PBM fees, and insurance subsidies to slash costs, which could redefine pricing power and consumer choice across the industry.
AI Overviews stumble on some health queries
As consumer health AI tools expand, companies must tread carefully or risk eroding consumer confidence.
Powerful data and analysis on nearly every digital topic.
Become a ClientWant more marketing insights?
Sign up for EMARKETER Daily, our free newsletter.
Thanks for signing up for our newsletter!
You can read recent articles from EMARKETER here.- Learn about what technologies are transforming your industry
- Gain exclusive perspectives from top industry leaders
- Access thousands of data sets and forecasts via our iconic charts